Synthesis of RGD containing peptides. Comparative study of their incorporation to the surface of 5-fluoruridine loaded liposomes

被引:5
作者
Massaguer, A
Haro, I
Alsina, MA
Reig, F
机构
[1] CSIC, IIQAB, Dept Peptide & Prot Chem, ES-08034 Barcelona, Spain
[2] Univ Barcelona, Fac Pharm, Physicochem Unit, E-08007 Barcelona, Spain
关键词
liposomes; peptide synthesis; vitreoretinopathies; 5-fluorouridine; surface activity; cell adhesion;
D O I
10.1081/LPR-100103173
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The synthesis on solid phase of a peptide sequence (GGRGRS) related to an integrin adhesion site as well as the preparation of some hydrophobic derivatives is described. The incorporation of these peptides to the surface of liposomes was carried out either through the NGPE (N-glutaryl dipalmitoyl phosphatidyl chorine) carboxyl-group or mixing hydrophobic peptide derivatives with lipids since the beginning of the process. The influence of these factors on the entrapment yield of 5-FUR (5-fluorouridine) was determined. Best results, calculated as percentage of drug encapsulation, were obtained when the peptide was linked to preformed liposomes via an NGPE-amide bond. On the contrary, the presence of these hydrophobic peptides on the bilayers decreases the overall yield of encapsulation of 5-FUR. Nevertheless, considering drug/lipid relationship and scaling-up requirements it seems that the use of myristoyl peptide derivative should be the procedure of choice. Physicochemical studies carried out with the peptides indicated that the presence of hydrophobic moieties linked to the parent peptide increases the tendency to self aggregation as detected through fluorescence studies using DPH (1, 6 diphenyl hexatriene) as marker, reducing in this way the efficiency of incorporation of hydrophobic peptides to the surface of liposomes.
引用
收藏
页码:103 / 113
页数:11
相关论文
共 12 条
[1]  
CASAROLI MRP, 1995, EXP EYE RES, V60, P5
[2]   CONCEPT AND PROGRESS IN THE DEVELOPMENT OF RGD-CONTAINING PEPTIDE PHARMACEUTICALS [J].
CRAIG, WS ;
CHENG, S ;
MULLEN, DG ;
BLEVITT, J ;
PIERSCHBACHER, MD .
BIOPOLYMERS, 1995, 37 (02) :157-175
[3]  
FONSECA MJ, 1994, THESIS U BARCELONA
[4]   Pharmacokinetics and retinal toxicity of intravitreal liposome-encapsulated 5-fluorouridine [J].
GarciaArumi, J ;
Pascual, R ;
Fonseca, MJ ;
Isart, FR ;
Casaroli, R ;
Mateo, C ;
Corcostegui, B .
OPHTHALMOLOGICA, 1997, 211 (06) :344-350
[5]   Physicochemical characterization of several peptide constructs related with hepatitis A and B viruses [J].
Gómara, MJ ;
Girona, V ;
Reig, F ;
Alsina, MA ;
Haro, I .
MATERIALS SCIENCE & ENGINEERING C-BIOMIMETIC AND SUPRAMOLECULAR SYSTEMS, 1999, 8-9 :487-493
[6]  
HEATH TD, 1986, INVEST OPHTH VIS SCI, V27, P940
[7]  
JARUS G, 1985, OPHTHALMOLOGY, V92, P91
[8]   SYNTHESIS AND PHYSICOCHEMICAL STUDY OF HEPATITIS-A VIRAL-VP1 PROTEIN-PEPTIDES [J].
MARTIN, I ;
HARO, I ;
REIG, F ;
ALSINA, MA .
LANGMUIR, 1994, 10 (03) :784-789
[9]   ACCURATE AND CONVENIENT ORGANIC PHOSPHORUS ASSAY [J].
MCCLARE, CWF .
ANALYTICAL BIOCHEMISTRY, 1971, 39 (02) :527-&
[10]   DEVELOPMENT OF GPIIB IIIA ANTAGONISTS AS ANTITHROMBOTIC DRUGS [J].
NICHOLS, AJ ;
RUFFOLO, RR ;
HUFFMAN, WF ;
POSTE, G ;
SAMANEN, J .
TRENDS IN PHARMACOLOGICAL SCIENCES, 1992, 13 (11) :413-417